{"pmid":32468843,"title":"Diabetes Care at the Times of Transition and COVID-19 Pandemics (Ukrainian Experience).","text":["Diabetes Care at the Times of Transition and COVID-19 Pandemics (Ukrainian Experience).","J Diabetes Sci Technol","Mankovsky, Boris","32468843"],"journal":"J Diabetes Sci Technol","authors":["Mankovsky, Boris"],"date":"2020-05-30T11:00:00Z","year":2020,"_id":"32468843","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1177/1932296820930031","keywords":["covid-19","ukraine","diabetes"],"locations":["Ukrainian"],"countries":["Ukraine"],"countries_codes":["UKR|Ukraine"],"topics":["Prevention"],"weight":1,"_version_":1668167109900763136,"score":9.490897,"similar":[{"pmid":32443943,"title":"Time for a Change: Personal Experiences With COVID-19 and Diabetes.","text":["Time for a Change: Personal Experiences With COVID-19 and Diabetes.","Personal experiences during the COVID-19 pandemic.","J Diabetes Sci Technol","Best, Frank","32443943"],"abstract":["Personal experiences during the COVID-19 pandemic."],"journal":"J Diabetes Sci Technol","authors":["Best, Frank"],"date":"2020-05-24T11:00:00Z","year":2020,"_id":"32443943","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1177/1932296820928083","keywords":["covid-19","diabetes","management","personal experience"],"topics":["Prevention"],"weight":1,"_version_":1667600475751448576,"score":63.540424},{"pmid":32369634,"title":"Guidelines for the management of diabetes in care homes during the Covid-19 pandemic.","text":["Guidelines for the management of diabetes in care homes during the Covid-19 pandemic.","The National Diabetes Stakeholders Covid-19 Response Group was formed in early April 2020 as a rapid action by the Joint British Diabetes Societies for Inpatient Care, Diabetes UK, the Association of British Clinical Diabetologists, and Diabetes Frail to address and support the special needs of residents with diabetes in UK care homes during Covid-19. It was becoming obvious that the care home sector was becoming a second wave of Covid-19 infection and that those with diabetes residing in care homes were at increased risk not only of susceptibility to infection but also to poorer outcomes. Its key purposes included minimising the morbidity and mortality associated with Covid-19 and assisting care staff to identify those residents with diabetes at highest risk of Covid-19 infection. The guidance was particularly created for care home managers, other care home staff, and specialist and non-specialist community nursing teams. The guidance covers the management of hyperglycaemia by discussion of various clinical scenarios that could arise, the management of hypoglycaemia, foot care and end of life care. In addition, it outlines the conditions where hospital admission is required. The guidance should be regarded as interim and will be updated as further medical and scientific evidence becomes available.","Diabet Med","Sinclair, Alan","Dhatariya, Ketan","Burr, Olivia","Nagi, Dinesh","Higgins, Kath","Hopkins, David","Patel, Mayank","Kar, Partha","Gooday, Catherine","Howarth, Dan","Abdelhafiz, Ahmed","Newland-Jones, Philip","O'Neill, Simon","32369634"],"abstract":["The National Diabetes Stakeholders Covid-19 Response Group was formed in early April 2020 as a rapid action by the Joint British Diabetes Societies for Inpatient Care, Diabetes UK, the Association of British Clinical Diabetologists, and Diabetes Frail to address and support the special needs of residents with diabetes in UK care homes during Covid-19. It was becoming obvious that the care home sector was becoming a second wave of Covid-19 infection and that those with diabetes residing in care homes were at increased risk not only of susceptibility to infection but also to poorer outcomes. Its key purposes included minimising the morbidity and mortality associated with Covid-19 and assisting care staff to identify those residents with diabetes at highest risk of Covid-19 infection. The guidance was particularly created for care home managers, other care home staff, and specialist and non-specialist community nursing teams. The guidance covers the management of hyperglycaemia by discussion of various clinical scenarios that could arise, the management of hypoglycaemia, foot care and end of life care. In addition, it outlines the conditions where hospital admission is required. The guidance should be regarded as interim and will be updated as further medical and scientific evidence becomes available."],"journal":"Diabet Med","authors":["Sinclair, Alan","Dhatariya, Ketan","Burr, Olivia","Nagi, Dinesh","Higgins, Kath","Hopkins, David","Patel, Mayank","Kar, Partha","Gooday, Catherine","Howarth, Dan","Abdelhafiz, Ahmed","Newland-Jones, Philip","O'Neill, Simon"],"date":"2020-05-06T11:00:00Z","year":2020,"_id":"32369634","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1111/dme.14317","keywords":["covid-19","diabetes","care homes","frailty","insulin","residents"],"locations":["GBR","GBR"],"countries":["United Kingdom"],"countries_codes":["GBR|United Kingdom"],"topics":["Prevention"],"weight":1,"_version_":1666138496241238016,"score":52.92802},{"pmid":32438687,"title":"The COVID-19 Pandemic during the Time of the Diabetes Pandemic: Likely Fraternal Twins?","text":["The COVID-19 Pandemic during the Time of the Diabetes Pandemic: Likely Fraternal Twins?","An altered immune response to pathogens has been suggested to explain increased susceptibility to infectious diseases in patients with diabetes. Recent evidence has documented several immunometabolic pathways in patients with diabetes directly related to the COVID-19 infection. This also seems to be the case for prediabetic subjects with proinflammatory insulin resistance syndrome accompanied with prothrombotic hyperinsulinemic and dysglycemic states. Patients with frank hyperglycemia, dysglycemia and/or hyperinsulinemia develop systemic immunometabolic inflammation with higher levels of circulating cytokines. This deleterious scenario has been proposed as the underlying mechanism enhancing a cytokine storm-like hyperinflammatory state in diabetics infected with severe COVID-19 triggering multi-organ failure. Compared with moderately affected COVID-19 patients, diabetes was found to be highly prevalent among severely affected patients suggesting that this non-communicable disease should be considered as a risk factor for adverse outcomes. The COVID-19 pandemic mirrors with the diabetes pandemic in many pathobiological aspects. Our interest is to emphasize the ties between the immunoinflammatory mechanisms that underlie the morbidity and lethality when COVID-19 meets diabetes. This review brings attention to two pathologies of highly complex, multifactorial, developmental and environmentally dependent manifestations of critical importance to human survival. Extreme caution should be taken with diabetics with suspected symptoms of COVID-19 infection.","Pathogens","Cole, Shelley A","Laviada-Molina, Hugo A","Serres-Perales, Jeannette M","Rodriguez-Ayala, Ernesto","Bastarrachea, Raul A","32438687"],"abstract":["An altered immune response to pathogens has been suggested to explain increased susceptibility to infectious diseases in patients with diabetes. Recent evidence has documented several immunometabolic pathways in patients with diabetes directly related to the COVID-19 infection. This also seems to be the case for prediabetic subjects with proinflammatory insulin resistance syndrome accompanied with prothrombotic hyperinsulinemic and dysglycemic states. Patients with frank hyperglycemia, dysglycemia and/or hyperinsulinemia develop systemic immunometabolic inflammation with higher levels of circulating cytokines. This deleterious scenario has been proposed as the underlying mechanism enhancing a cytokine storm-like hyperinflammatory state in diabetics infected with severe COVID-19 triggering multi-organ failure. Compared with moderately affected COVID-19 patients, diabetes was found to be highly prevalent among severely affected patients suggesting that this non-communicable disease should be considered as a risk factor for adverse outcomes. The COVID-19 pandemic mirrors with the diabetes pandemic in many pathobiological aspects. Our interest is to emphasize the ties between the immunoinflammatory mechanisms that underlie the morbidity and lethality when COVID-19 meets diabetes. This review brings attention to two pathologies of highly complex, multifactorial, developmental and environmentally dependent manifestations of critical importance to human survival. Extreme caution should be taken with diabetics with suspected symptoms of COVID-19 infection."],"journal":"Pathogens","authors":["Cole, Shelley A","Laviada-Molina, Hugo A","Serres-Perales, Jeannette M","Rodriguez-Ayala, Ernesto","Bastarrachea, Raul A"],"date":"2020-05-23T11:00:00Z","year":2020,"_id":"32438687","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.3390/pathogens9050389","keywords":["covid-19","gemm family study","adipose tissue dysfunction","cytokine storm","diabetes","inflammation"],"topics":["Mechanism"],"weight":1,"_version_":1667535119526658048,"score":51.047028},{"pmid":32486900,"title":"Inpatient Diabetes Management During the COVID-19 Crisis: Experiences From Two Community Hospitals.","text":["Inpatient Diabetes Management During the COVID-19 Crisis: Experiences From Two Community Hospitals.","J Diabetes Sci Technol","Shelton, Carter","Demidowich, Andrew P","Zilbermint, Mihail","32486900"],"journal":"J Diabetes Sci Technol","authors":["Shelton, Carter","Demidowich, Andrew P","Zilbermint, Mihail"],"date":"2020-06-04T11:00:00Z","year":2020,"_id":"32486900","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1177/1932296820930268","keywords":["community hospital","diabetes","inpatient","management","telehealth","telemedicine"],"topics":["Prevention"],"weight":1,"_version_":1668892169356705792,"score":50.63113},{"pmid":32460553,"title":"Would You Believe? A Virus Changes Diabetes Care.","text":["Would You Believe? A Virus Changes Diabetes Care.","J Diabetes Sci Technol","Tack, Cornelis Cees J","32460553"],"journal":"J Diabetes Sci Technol","authors":["Tack, Cornelis Cees J"],"date":"2020-05-29T11:00:00Z","year":2020,"_id":"32460553","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1177/1932296820929381","keywords":["covid-19","icu","diabetes","obesity","remote diabetes care","telehealth"],"weight":0,"_version_":1668079521552662528,"score":49.897167}]}